Key result
N93K mutation reduces functional NM2-A by promoting aggregation and filament stability, unlike E1841K.
Why the study?
Correlation between MYH9 genotype and phenotype is not well characterized at a molecular level, though motor mutations appear to cause more severe phenotypes than tail mutations.
The study provides a molecular explanation for the genotype-phenotype correlation in MYH9-related disease, showing that motor mutations (N93K) cause more severe cellular defects by co-aggregating with wild type protein compared to tail mutations (E1841K).
Hypothesis-generating for MYH9 mutation severity in models; leaves open clinical translation pending human data.
-RD). While correlation between genotype and phenotype is not well characterized at a molecular level, motor mutations seem to cause more severe phenotypes than tail mutations. Motor domain mutation N93K, previously described as activity-impairing, causes in fact an almost non-significant defect on motor function in vitro. Conversely, it increases NM2-A filament stability and interaction with the myosin chaperone UNC45a in stress fiber-forming cells. This also alters its subcellular localization and effect on adhesion dynamics. Similar cellular effects are observed in cells expressing NM2-A E1841K, a prototypical tail mutation. In cells devoid of stress fibers such as megakaryocytes, NM2-A N93K forms large, amorphous, concentration-dependent aggregates that also contain wild type NM2-A and UNC45a. Conversely, NM2-A E1841K forms concentration-independent aggregates that exclude wild type NM2-A and UNC45a. Our data shows that the N93K mutation reduces the fraction of functional cellular NM2-A by enhancing the stability of NM2-A filaments and/or promoting protein aggregation together with wild type NM2-A. Conversely, NM2-A E1841K form aggregates that do not affect wild type NM2-A. These observations are consistent with the molecular severity observed in primary cells from patients of these genotypes.
No takes yet. Share an insight, caveat, or question.
Llorente-González et al. (2025) studied MYH9-related disease. MYH9 mutations (N93K and E1841K) vs. Wild type NM2-A was evaluated on NM2-A aggregation and intracellular dynamics. The motor domain mutation N93K reduces functional cellular NM2-A by enhancing filament stability and promoting aggregation with wild-type NM2-A, unlike the tail mutation E1841K.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: